Skycraper Clinical Research Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.49 M
- Paid Up Capital ₹ 60.00 K
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -39.94%
- Profit Growth 158.14%
- Ebitda 203.59%
- Net Worth 55.05%
- Total Assets 111.62%
About Skycraper Clinical Research Solutions
Skycraper Clinical Research Solutions Private Limited (SCRSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 March 2017 (Seven years and ten months 21 days old ). Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.49 M and a paid-up capital of Rs 60.00 K , as per Ministry of Corporate Affairs (MCA) records.
Chintan Sheth and Naynaben Vyas serve as directors at the Company.
Company Details
-
Location
Mahesana, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100GJ2017PTC096490
-
Company No.
096490
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Mar 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Skycraper Clinical Research Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chintan Sheth
|
Director | 24-Mar-2017 | Current |
|
Naynaben Vyas
|
Director | 05-Oct-2021 | Current |
Financial Performance of Skycraper Clinical Research Solutions.
Skycraper Clinical Research Solutions Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 39.94% decrease. The company also saw a substantial improvement in profitability, with a 158.14% increase in profit. The company's net worth Soared by an impressive increase of 55.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skycraper Clinical Research Solutions?
Unlock access to Skycraper Clinical Research Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tripadaclinical Solutions Private LimitedChintan Sheth and Naynaben Vyas are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skycraper Clinical Research Solutions?
Unlock and access historical data on people associated with Skycraper Clinical Research Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skycraper Clinical Research Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skycraper Clinical Research Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
